Literature DB >> 28496565

An Improved QT Correction Method for use in Atrial Fibrillation and a Comparison with the Assessment of QT in Sinus Rhythm.

Deepak Saluja1, Jason A Guyotte2, James A Reiffel1.   

Abstract

BACKGROUND: Conventional QT corrections may be inappropriate inatrial fibrillation (AF) due to RR variability and QT lag. Existing formulashave been modified by the formula RRmod to account for this lag. Wedeveloped a novel correction formula for use in AF (QTAF) based onthe slope ∆QT/∆RRmod and report its performance in AF.We also compare QTAF obtained in AF with rate-independentcorrections in NSR.
MATERIALS AND METHODS: A total of 3063 RR/QT pairs from 28 patients with AFwere measured, 22 of whom also had measurements during sinus rhythm. QTc (theBazett equation), QTLC (the Framingham linear correction), and QTAFwere calculated utilizing RRmod, and the rate-independence of eachformula in AF tested. Mean QTAF values in AF were compared to QTintervals corrected with QTLC in normal sinus rhythm.
RESULTS: ∆QTc/∆RRmod and∆QTLC/∆RRmod slopes were significantlynon-zero whereas ∆QTAF/∆RRmod was not. QTLCand QTc corrections were imperfect at extremes of RRmod whileQTAF was constant. QTAF corrections in AF were shorterthan QTc or QTLC corrections in NSR.
CONCLUSIONS: QTAF is a novel QT correction with adefined relationship to correction in NSR that performs better than existingstrategies.

Entities:  

Year:  2008        PMID: 28496565      PMCID: PMC5398790          DOI: 10.4022/jafib.9

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  24 in total

1.  Estimation of the QT/RR hysteresis lag.

Authors:  Esther Pueyo; Peter Smetana; Pablo Laguna; Marek Malik
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

2.  Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings.

Authors:  J Molnar; J Weiss; F Zhang; J E Rosenthal
Journal:  Am J Cardiol       Date:  1996-10-15       Impact factor: 2.778

3.  Effects of the ventricular activation sequence on the JT interval.

Authors:  J Banker; J Dizon; J Reiffel
Journal:  Am J Cardiol       Date:  1997-03-15       Impact factor: 2.778

4.  Beat-to-beat QT dynamics in paroxysmal atrial fibrillation.

Authors:  Charlotte E Larroude; Berit T Jensen; Erik Agner; Egon Toft; Christian Torp-Pedersen; Kristian Wachtell; Jørgen K Kanters
Journal:  Heart Rhythm       Date:  2006-06       Impact factor: 6.343

5.  Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

Authors:  M Malik; P Färbom; V Batchvarov; K Hnatkova; A J Camm
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

6.  Exaggerated QT prolongation after cardioversion of atrial fibrillation.

Authors:  A M Choy; D Darbar; S Dell'Orto; D M Roden
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

7.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

8.  Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.

Authors:  V Velebit; P Podrid; B Lown; B H Cohen; T B Graboys
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

9.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

10.  Influence of heart rate and inhibition of autonomic tone on the QT interval.

Authors:  S Ahnve; H Vallin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

View more
  1 in total

Review 1.  Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation.

Authors:  Ademuyiwa S Aromolaran; Mohamed Boutjdir
Journal:  Front Physiol       Date:  2017-06-21       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.